Peritoneal Neoplasms: all 366 studies
Page 3 of 4. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Intravital Microscopy (IVM) in Patients With Peritoneal Carcinomatosis (PC)CompletedNCT03517852Not applicable
- Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisCompletedNCT03508570Phase 1
- Debulking Surgery in Ovarian CancerCompletedNCT03378128Not applicable
- Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal ChemotherapyCompletedNCT03364907
- Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.Active, not recruitingNCT03348150Phase 3
- Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal CancerCompletedNCT03332576Phase 1
- Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -CompletedNCT03287375Phase 2
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric CancerCompletedNCT03253939
- Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRCCompletedNCT03253133Phase 1
- Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid TumorsActive, not recruitingNCT03252938Phase 1
- PIPAC for Peritoneal Metastases of Colorectal CancerCompletedNCT03246321Phase 2
- Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric CancerStatus unknownNCT03179579Phase 3
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal CarcinomatosisActive, not recruitingNCT03172416Phase 1
- EDMONd - Elemental Diet in Bowel ObstructionStatus unknownNCT03150992Not applicable
- Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility StudyTerminatedNCT03150628Phase 2
- Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical CarcinomaActive, not recruitingNCT03127774Phase 2
- Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort StudyStatus unknownNCT03124394
- Register Study of Patients With Peritoneal Carcinomatosis Treated With PIPAC (Pressurized Intra-peritoneal Aerosol-Chemotherapy)Status unknownNCT03100708
- Thrombin Generation and Platelet Activation in CRS/HIPECCompletedNCT03034850
- Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' TreatmentStatus unknownNCT03028155Phase 3
- PET Imaging of Ovarian Carcinoma With 18F-FSPGWithdrawnNCT02872519Early Phase 1
- Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal CarcinosisStatus unknownNCT02840331Phase 3
- French National Registry of Rare Peritoneal Surface MalignanciesStatus unknownNCT02834169
- Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRICompletedNCT02833753Phase 1
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT02833506Phase 1
- Study Comparing the Role of the Laparoscopy Surgical Staging in the Peritoneal Carcinomatosis to Laparotomic ApproachStatus unknownNCT02829788
- Clinical and Biological Digestive Peritoneal Carcinomatosis Data Base From the French National Network of Peritoneal Surface MalignanciesCompletedNCT02823860Not applicable
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) : Predictive Marker and MechanismTerminatedNCT02803515Not applicable
- Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving ChemotherapyCompletedNCT02786524Not applicable
- Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive CancerCompletedNCT02784028Not applicable
- Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal MetastasesActive, not recruitingNCT02758951Phase 2/3
- Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian OriginWithdrawnNCT02667925Not applicable
- Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsCompletedNCT02658214Phase 1
- Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal TumorsCompletedNCT02604784Phase 1/2
- Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic MalignanciesCompletedNCT02578888Not applicable
- PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian CancerActive, not recruitingNCT02571725Phase 1/2
- DNA Single Nucleotide Polymorphisms as Predictors of ToxicityStatus unknownNCT02478476
- A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal CarcinomatosisCompletedNCT02475772Phase 1
- Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or RecurrentWithdrawnNCT02470559Phase 1
- A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface MalignancyCompletedNCT02463877Phase 2
- Risk Factors for Early POCD in the Patients With PSM Undergoing CRS-HIPECCompletedNCT02462564
- p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal CancerStatus unknownNCT02435186Phase 2
- Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal CarcinomatosisTerminatedNCT02420509
- Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal CarcinomaStatus unknownNCT02328716Phase 3
- The Intraoperative Physiologic Changes of Patients Under Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Cytoreductive Surgery; Prospective Observational StudyCompletedNCT02325648
- Treating Peritoneal Carcinomatosis With PIPACCompletedNCT02320448Phase 2
- Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02316834Early Phase 1
- A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal CancerWithdrawnNCT02277392Phase 1
- Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa TrialCompletedNCT02219893Phase 1/2
- Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal CarcinomatosisCompletedNCT02179489Not applicable
- Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal CarcinomatosisCompletedNCT02158988Phase 3
- HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data RegistryCompletedNCT02082886
- Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02042430Early Phase 1
- Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal CancerCompletedNCT02032485Phase 2
- Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal CarcinomatosisCompletedNCT02024841Phase 1
- Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
- Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer OriginWithdrawnNCT02017678Phase 2
- Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in RemissionWithdrawnNCT01982487Phase 1/2
- FloSeal in CRS and HIPECCompletedNCT01957852
- An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerCompletedNCT01932125Phase 4
- Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)CompletedNCT01882920Not applicable
- Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma PatientsCompletedNCT01834469Phase 1/2
- BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian CancerCompletedNCT01788995
- Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using CatumaxomabTerminatedNCT01784900Phase 2
- Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerCompletedNCT01764802Phase 2
- Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerCompletedNCT01764789Not applicable
- An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)CompletedNCT01697488
- Intra Peritoneal Chemo Hyperthermia (IPCH) : Cellular and Metabolic ConsequencesTerminatedNCT01685632Not applicable
- Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01606241Phase 1
- Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal CarcinomatosisCompletedNCT01575730Phase 2
- A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal CancerStatus unknownNCT01570582Phase 2
- Representation of the Body for Patients With CancerCompletedNCT01560533Not applicable
- CAre of Patients With PArenteral Nutrition At HomeCompletedNCT01545063
- Combined Anticancer Treatment of Advanced Colon CancerTerminatedNCT01540344Phase 2
- Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian CancerCompletedNCT01538498
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT01536054Phase 1
- Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal CarcinomatosisCompletedNCT01524094Phase 3
- Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric AdenocarcinomasCompletedNCT01504256Phase 2
- Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01504126Early Phase 1
- Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian CancerTerminatedNCT01494012Phase 1
- A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT01478685Phase 1
- Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian CancerCompletedNCT01462890Phase 3
- A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal CarcinomatosisCompletedNCT01443260Phase 1/2
- Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal CancerCompletedNCT01416038Phase 1
- Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio ImmunotherapyCompletedNCT01384253Phase 1
- Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric CancerCompletedNCT01379482Phase 2
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerStatus unknownNCT01366183
- Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric CarcinomatosisSuspendedNCT01342653Phase 2
- Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT01339650Phase 1
- A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis PatientsTerminatedNCT01300858Phase 1/2
- Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian CancerTerminatedNCT01279291Phase 1
- Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal CancerCompletedNCT01264432Phase 1
- Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First RemissionCompletedNCT01248273Phase 1
- Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and IrinotecanCompletedNCT01226550Phase 1/2
- Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal PatientsCompletedNCT01226394Phase 3
- Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPECWithdrawnNCT01225757Not applicable
- TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube CancerCompletedNCT01204749Phase 3
- Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal CancerTerminatedNCT01116791Phase 2
- Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerStatus unknownNCT01100372Phase 2
- Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal MetastasesWithdrawnNCT01095523Phase 2